101 related articles for article (PubMed ID: 10893233)
1. Delayed reversal of shape change in cells expressing FP(B) prostanoid receptors. Possible role of receptor resensitization.
Fujino H; Pierce KL; Srinivasan D; Protzman CE; Krauss AH; Woodward DF; Regan JW
J Biol Chem; 2000 Sep; 275(38):29907-14. PubMed ID: 10893233
[TBL] [Abstract][Full Text] [Related]
2. FP prostanoid receptor activation of a T-cell factor/beta -catenin signaling pathway.
Fujino H; Regan JW
J Biol Chem; 2001 Apr; 276(16):12489-92. PubMed ID: 11278257
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of prostaglandin F(2alpha) receptor isoforms by protein kinase C.
Fujino H; Srinivasan D; Pierce KL; Regan JW
Mol Pharmacol; 2000 Feb; 57(2):353-8. PubMed ID: 10648645
[TBL] [Abstract][Full Text] [Related]
4. Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton.
Pierce KL; Fujino H; Srinivasan D; Regan JW
J Biol Chem; 1999 Dec; 274(50):35944-9. PubMed ID: 10585482
[TBL] [Abstract][Full Text] [Related]
5. Differential internalization of the prostaglandin f(2alpha) receptor isoforms: role of protein kinase C and clathrin.
Srinivasan D; Fujino H; Regan JW
J Pharmacol Exp Ther; 2002 Jul; 302(1):219-24. PubMed ID: 12065720
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of Ca(2+)-dependent Cl- currents by FP prostanoid receptor isoforms in Xenopus oocytes.
Anthony TL; Fujino H; Pierce KL; Yool AJ; Regan JW
Biochem Pharmacol; 2002 May; 63(10):1797-806. PubMed ID: 12034364
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 selectively antagonizes prostaglandin F2alpha-stimulated T-cell factor/beta-catenin signaling pathway by the FPB prostanoid receptor.
Fujino H; Vielhauer GA; Regan JW
J Biol Chem; 2004 Oct; 279(42):43386-91. PubMed ID: 15280380
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.
Fujino H; West KA; Regan JW
J Biol Chem; 2002 Jan; 277(4):2614-9. PubMed ID: 11706038
[TBL] [Abstract][Full Text] [Related]
9. Cloning of a carboxyl-terminal isoform of the prostanoid FP receptor.
Pierce KL; Bailey TJ; Hoyer PB; Gil DW; Woodward DF; Regan JW
J Biol Chem; 1997 Jan; 272(2):883-7. PubMed ID: 8995377
[TBL] [Abstract][Full Text] [Related]
10. Cellular conditioning and activation of beta-catenin signaling by the FPB prostanoid receptor.
Fujino H; Srinivasan D; Regan JW
J Biol Chem; 2002 Dec; 277(50):48786-95. PubMed ID: 12368277
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin F(2alpha) stimulation of cyclooxygenase-2 promoter activity by the FP(B) prostanoid receptor.
Fujino H; Regan JW
Eur J Pharmacol; 2003 Mar; 465(1-2):39-41. PubMed ID: 12650831
[TBL] [Abstract][Full Text] [Related]
12. Suppression of protein kinase C signaling by the novel isoform for bovine PGF(2alpha) receptor.
Ishii Y; Sakamoto K
Biochem Biophys Res Commun; 2001 Jul; 285(1):1-8. PubMed ID: 11437363
[TBL] [Abstract][Full Text] [Related]
13. Role of the ERC motif in the proximal part of the second intracellular loop and the C-terminal domain of the human prostaglandin F2alpha receptor (hFP-R) in G-protein coupling control.
Pathe-Neuschäfer-Rube A; Neuschäfer-Rube F; Püschel GP
Biochem J; 2005 May; 388(Pt 1):317-24. PubMed ID: 15651980
[TBL] [Abstract][Full Text] [Related]
14. FP prostanoid receptor-mediated induction of the expression of early growth response factor-1 by activation of a Ras/Raf/mitogen-activated protein kinase signaling cascade.
Xu W; Chou CL; Sun H; Fujino H; Chen QM; Regan JW
Mol Pharmacol; 2008 Jan; 73(1):111-8. PubMed ID: 17911534
[TBL] [Abstract][Full Text] [Related]
15. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.
Kelly CR; Williams GW; Sharif NA
J Pharmacol Exp Ther; 2003 Jan; 304(1):238-45. PubMed ID: 12490597
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin D(2) receptor-mediated desensitization of the alpha isoform of the human thromboxane A(2) receptor.
Foley JF; Kelley LP; Kinsella BT
Biochem Pharmacol; 2001 Jul; 62(2):229-39. PubMed ID: 11389883
[TBL] [Abstract][Full Text] [Related]
17. EP1- and FP-mediated cross-desensitization of the alpha (alpha) and beta (beta) isoforms of the human thromboxane A2 receptor.
Kelley-Hickie LP; Kinsella BT
Br J Pharmacol; 2004 May; 142(1):203-21. PubMed ID: 15100160
[TBL] [Abstract][Full Text] [Related]
18. Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK-CREB cascade.
Ueno T; Fujimori K
FEBS J; 2011 Aug; 278(16):2901-12. PubMed ID: 21668646
[TBL] [Abstract][Full Text] [Related]
19. Prostanoid receptors: subtypes and signaling.
Breyer RM; Bagdassarian CK; Myers SA; Breyer MD
Annu Rev Pharmacol Toxicol; 2001; 41():661-90. PubMed ID: 11264472
[TBL] [Abstract][Full Text] [Related]
20. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
Sharif NA; Kelly CR; Crider JY
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):715-21. PubMed ID: 12556403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
